STOCK TITAN

Bon Natural Life Limited Launches Three New Cruciferous Vegetable-Based Powder Drinks

Rhea-AI Impact
(Moderate)
Rhea-AI Sentiment
(Neutral)
Tags

XI'AN, China, June 02, 2023 (GLOBE NEWSWIRE) -- Bon Natural Life Limited (Nasdaq: BON) ("BON" or the "Company"), one of the leading bio-ingredient solutions providers in the natural, health and personal care industries, today announced the launch of three powder drinks to its cruciferous vegetable-based health supplement series. The new powder drinks include: broccoli seed caffeine powder drink, broccoli seed coconut powder drink, and broccoli seed green tea powder drink.

Thoughtfully formulated, the combination of broccoli seed extract and BON’s proprietary prebiotic stachyose can help regulate microbiome health to improve one’s immune system and overall health.

“We are thrilled to expand the line of our cruciferous vegetable-based supplement series with the announcement of the new powder drinks.” Commented Mr. Richard (Yongwei) Hu, CEO and Chairman of BON, “This marks another important step in our expansion into the consumer market. According to the research by Daxue Consulting, health-awareness is growing and influencing the beverage industry in China. Leveraging our technology and experience, BON’s three new powder drinks are able to create a comprehensive product suite to the health-conscious young consumers. We are optimistic about the market opportunity and the potential revenue growth from our nutraceutical powder drinks.”

About Bon Natural Life Limited

The Company focuses on the manufacturing of personal care ingredients, such as plant extracted fragrance compounds for perfume and fragrance manufacturers, natural health supplements such as powder drinks and bioactive food ingredient products mostly used as food additives and nutritional supplements by their customers. For additional information, please visit the Company’s website at www.bnlus.com.

Safe Harbor Statement

This press release contains forward-looking statements as defined by the Private Securities Litigation Reform Act of 1995. Forward-looking statements include statements concerning plans, objectives, goals, strategies, future events or performance, and underlying assumptions and other statements that are other than statements of historical facts. When the Company uses words such as "may, "will, "intend," "should," "believe," "expect," "anticipate," "project," "estimate" or similar expressions that do not relate solely to historical matters, it is making forward-looking statements. Forward-looking statements are not guarantees of future performance and involve risks and uncertainties that may cause the actual results to differ materially from the Company's expectations discussed in the forward-looking statements. These statements are subject to uncertainties and risks including, but not limited to, the following: the Company's goals and strategies; the Company's future business development; product and service demand and acceptance; changes in technology; economic conditions; the growth of the natural, health and personal care market in China and the other international markets the Company plans to serve; reputation and brand; the impact of competition and pricing; government regulations; fluctuations in general economic and business conditions in China and the international markets the Company plans to serve and assumptions underlying or related to any of the foregoing and other risks contained in reports filed by the Company with the SEC. For these reasons, among others, investors are cautioned not to place undue reliance upon any forward-looking statements in this press release. Additional factors are discussed in the Company's filings with the SEC, which are available for review at www.sec.gov. The Company undertakes no obligation to publicly revise these forward–looking statements to reflect events or circumstances that arise after the date hereof.

For more information, please contact:

In the United States: 
Maggie Zhang | Impact IRSophie Zhang | Impact IR
Email: maggie.zhang@irimpact.comEmail: sophie.zhang@irimpact.com


Bon Natural Life Limited Ordinary Shares

NASDAQ:BON

BON Rankings

BON Latest News

BON Stock Data

5.52M
3.71M
6.58%
1.75%
1.27%
Specialty Chemicals
Basic Materials
Link
United States of America
Xi'an